ABVC BioPharma Inc Q1 2025 Earnings Narrowed Loss Highlights Continued Pipeline Progress ALZN Q1 2026 Earnings Narrowing Losses Beat Estimates by 70 TDS Q1 2026 Earnings Massive EPS Surprise Fails to Lift Stock CTO Realty Growth Q1 2026 Earnings Massive EPS Beat Sends Mixed Signals as Stock Edges Lower EPAC Q1 2026 Earnings EPS Falls Slightly Short of Estimates Shares Edge Higher COSO Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher on Resilient Fundamentals